Jasper Hellweg
Stock Analyst at Argus Research
(4.10)
# 1,599
Out of 4,495 analysts
232
Total ratings
55.4%
Success rate
7.5%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 68.63 | $54.04 | +26.99% | 5 | Jul 1, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $24.62 | - | 7 | Jun 23, 2026 | |
| GSK GSK plc | Maintained: Buy | n/a | $52.47 | - | 2 | Jun 8, 2026 | |
| NVS Novartis AG | Rated: Buy | $180 → $160 | $154.62 | +3.48% | 2 | Jun 4, 2026 | |
| ZTS Zoetis | Downgraded: Hold | n/a | $75.08 | - | 12 | May 26, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $220 → $250 | $249.91 | +0.04% | 5 | May 13, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $130 | $125.07 | +3.94% | 5 | May 8, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Buy | $55 | $52.02 | +5.73% | 3 | Apr 6, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | n/a | $48.88 | - | 7 | Mar 20, 2026 | |
| UTHR United Therapeutics | Rated: Buy | $345 → $560 | $552.48 | +1.36% | 11 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $76.56 | - | 14 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $198.91 | - | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $57.94 | - | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $667.95 | n/a | 13 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $134.84 | n/a | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $100 | $193.76 | n/a | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $22.46 | n/a | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $33.10 | n/a | 9 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,216.95 | n/a | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.34 | n/a | 4 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $360 | $363.62 | n/a | 6 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $60 | $43.90 | n/a | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $465 → $550 | $496.50 | n/a | 11 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $125 | $91.95 | n/a | 8 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $70 | $118.52 | n/a | 6 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 | $4.75 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $285 → $225 | $166.66 | n/a | 6 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $277.63 | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $165 | $208.05 | n/a | 6 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $475 → $500 | $420.39 | n/a | 5 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $290 | $208.97 | n/a | 5 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 → $275 | $409.01 | n/a | 6 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $50 | $44.99 | n/a | 3 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.18 | n/a | 5 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $135 | $95.55 | n/a | 5 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $115 | $51.65 | n/a | 4 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.41 | n/a | 3 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $322.61 | n/a | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $37.47 | n/a | 1 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $22.70 | n/a | 2 | Aug 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $228.50 | n/a | 1 | Aug 31, 2016 |
Alcon Inc.
Jul 1, 2026
Maintained: Buy
Price Target: CHF 68.63
Current: $54.04
Upside: +26.99%
Elanco Animal Health
Jun 23, 2026
Maintained: Buy
Price Target: n/a
Current: $24.62
Upside: -
GSK plc
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $52.47
Upside: -
Novartis AG
Jun 4, 2026
Rated: Buy
Price Target: $180 → $160
Current: $154.62
Upside: +3.48%
Zoetis
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $75.08
Upside: -
AbbVie
May 13, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $249.91
Upside: +0.04%
Merck & Co.
May 8, 2026
Reiterated: Buy
Price Target: $130
Current: $125.07
Upside: +3.94%
Roche Holding AG
Apr 6, 2026
Upgraded: Buy
Price Target: $55
Current: $52.02
Upside: +5.73%
Novo Nordisk
Mar 20, 2026
Maintained: Hold
Price Target: n/a
Current: $48.88
Upside: -
United Therapeutics
Mar 3, 2026
Rated: Buy
Price Target: $345 → $560
Current: $552.48
Upside: +1.36%
Jan 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $76.56
Upside: -
Jan 9, 2026
Maintained: Hold
Price Target: n/a
Current: $198.91
Upside: -
Jan 7, 2026
Maintained: Hold
Price Target: n/a
Current: $57.94
Upside: -
Jun 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $667.95
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: $100 → $120
Current: $134.84
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $150 → $100
Current: $193.76
Upside: n/a
Feb 24, 2025
Upgraded: Buy
Price Target: $40
Current: $22.46
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: $20
Current: $33.10
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: n/a
Current: $1,216.95
Upside: n/a
Jan 6, 2025
Maintained: Hold
Price Target: n/a
Current: $16.34
Upside: n/a
Aug 20, 2024
Maintained: Buy
Price Target: $340 → $360
Current: $363.62
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $55 → $60
Current: $43.90
Upside: n/a
Jun 17, 2024
Maintained: Buy
Price Target: $465 → $550
Current: $496.50
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $105 → $125
Current: $91.95
Upside: n/a
Apr 25, 2024
Maintained: Buy
Price Target: $90 → $70
Current: $118.52
Upside: n/a
Dec 7, 2022
Upgraded: Buy
Price Target: $26
Current: $4.75
Upside: n/a
Oct 24, 2022
Maintained: Buy
Price Target: $285 → $225
Current: $166.66
Upside: n/a
Sep 19, 2022
Downgraded: Hold
Price Target: n/a
Current: $277.63
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $135 → $165
Current: $208.05
Upside: n/a
Feb 7, 2022
Maintained: Buy
Price Target: $475 → $500
Current: $420.39
Upside: n/a
Sep 10, 2021
Maintained: Buy
Price Target: $260 → $290
Current: $208.97
Upside: n/a
Aug 2, 2021
Maintained: Buy
Price Target: $195 → $275
Current: $409.01
Upside: n/a
Jun 7, 2021
Maintained: Buy
Price Target: $43 → $50
Current: $44.99
Upside: n/a
May 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $8.18
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $95 → $135
Current: $95.55
Upside: n/a
Jun 12, 2020
Maintained: Buy
Price Target: $135 → $115
Current: $51.65
Upside: n/a
Apr 17, 2020
Downgraded: Hold
Price Target: n/a
Current: $10.41
Upside: n/a
Mar 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $322.61
Upside: n/a
Oct 30, 2019
Downgraded: Hold
Price Target: n/a
Current: $37.47
Upside: n/a
Aug 15, 2019
Upgraded: Buy
Price Target: $40
Current: $22.70
Upside: n/a
Aug 31, 2016
Downgraded: Hold
Price Target: n/a
Current: $228.50
Upside: n/a